Subgroup analysis for ET and PV patients was subsequently performed, revealing that the relationship between high JAK2 allelic burdens and the above-stated haematological parameters were not significant in the ET subgroup (Table 3). This evidence concerns the gene JAK2 and essential thrombocythemia.